Lumbar Spine Degeneration

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

3Spine
3SpineTN - Chattanooga
2 programs
Lumbar Interbody FusionN/A1 trial
MOTUS Total Joint ReplacementN/A1 trial
Active Trials
NCT04823858Active Not RecruitingEst. Nov 2029
NCT05438719Active Not RecruitingEst. Jun 2029

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
3SpineMOTUS Total Joint Replacement
3SpineLumbar Interbody Fusion

Clinical Trials (2)

NCT054387193SpineMOTUS Total Joint Replacement

MOTUS Total Joint Replacement Investigational Device Exemption Study

Start: Jun 2022Est. completion: Jun 2029
N/AActive Not Recruiting
NCT048238583SpineLumbar Interbody Fusion

3Spine Lumbar Fusion Real World Evidence Study

Start: May 2021Est. completion: Nov 2029
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space